1.Cuthbert, JA. Hepatitis A: old and new. Clinical Microbiology Reviews 2001; 14: 38–58.
2.Luyten, J, Beutels, P. Costing infectious disease outbreaks for economic evaluation: a review for hepatitis A. Pharmacoeconomics 2009; 27: 379–389.
3.Jung, YM, et al. Atypical manifestations of hepatitis A infection: a prospective, multicenter study in Korea. Journal of Medical Virology 2010; 82: 1318–1326.
4.Kim, JI, et al. Factors influencing the severity of acute viral hepatitis A. Korean Journal of Hepatology 2010; 16: 295–300.
5.Schiff, ER. Atypical clinical manifestations of hepatitis A. Vaccine 1992; 10 (Suppl. 1): S18–20.
6.Taylor, RM, et al. Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes. Hepatology 2006; 44: 1589–1597.
7.Brown, GR, Persley, K. Hepatitis A epidemic in the elderly. Southern Medical Journal 2002; 95: 826–833.
8.Willner, IR, et al. Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States. Annals of Internal Medicine 1998; 128: 111–114.
9.Hendrickx, G, et al. Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology. Journal of Viral Hepatitis 2008; 15 (Suppl. 2): 1–15.
10.Lee, D, et al. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy. Intervirology 2008; 51: 70–74.
11.Shliakhtenko, L, et al. Modern epidemiology of hepatitis A in the north-western region of the Russian Federation. Journal of Viral Hepatitis 2008; 15 (Suppl. 2): 38–42.
12.Tosti, ME, et al. Acute hepatitis A in Italy: incidence, risk factors and preventive measures. Journal of Viral Hepatitis 2008; 15 (Suppl. 2): 26–32.
13.Vitral, CL, Souto, FJ, Gaspar, AM. Changing epidemiology of hepatitis A in Brazil: reassessing immunization policy. Journal of Viral Hepatogy 2008; 15 (Suppl. 2): 22–25.
14.Jacobsen, KH, Wiersma, ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010; 28: 6653–6657.
15.Xu, ZY, et al. Decline in the risk of hepatitis A virus infection in China, a country with booming economy and changing lifestyles. Journal of Viral Hepatitis 2008; 15 (Suppl. 2): 33–37.
16.Kim, YJ, Lee, HS. Increasing incidence of hepatitis A in Korean adults. Intervirology 2010; 53: 10–14.
17.Song, YB, et al. The age-specific seroprevalence of hepatitis A virus antibody in Korea. Korean Journal of Hepatology 2007; 13: 27–33.
18.Lee, SH, et al. Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea. Korean Journal of Hepatology 2010; 16: 362–368.
19.Koslap-Petraco, MB, Shub, M, Judelsohn, R. Hepatitis A: disease burden and current childhood vaccination strategies in the United States. Journal of Pediatric Health Care; 22: 3–11.
20.Lee, SG, et al. Clinical features of hepatitis A in Korean adults. Korean Journal of Medicine 1999; 56: 685–690.
21.Korea National Institute of Health.Outbreak of hepatitis A viral infection in Hwacheon, Gangwon province. Communicable Diseases Monthly Report 1998; 9: 82.
22.Jung, YK, Kim, JH. Epidemiology and clinical features of acute hepatitis A: from the domestic perspective. Korean Journal of Hepatology 2009; 15: 438–445.
23.Kwon, SY. Current status of liver diseases in Korea: hepatitis A. Korean Journal of Hepatology 2009; 15 (Suppl. 6): S7–12.
25.Shapiro, CN, Margolis, HS. Worldwide epidemiology of hepatitis A virus infection. Journal of Hepatology 1993; 18 (Suppl. 2): S11–14.
26.Kim, JH, et al. A survey for seroprevalence of antibody to hepatitis A and development of policy in Seoul. Korea Centers for Disease Control and Prevention, 2006, pp. 1–41.
27.Byun, KS, et al. Molecular epidemiology of hepatitis A virus in Korea. Journal of Gastroenterology and Hepatology 2001; 16: 519–524.
28.Yun, H, et al. Genetic analysis of HAV strains isolated from patients with acute hepatitis in Korea, 2005–2006. Journal of Medical Virology 2008; 80: 777–784.
29.Yoon, YK, et al. Epidemiological and genetic analysis of a sustained community-wide outbreak of hepatitis A in the Republic of Korea, 2008: A hospital-based case-control study. Journal of Clinical Virology 2009; 46: 184–188.
31.Kim, JH. Recent epidemiological status and vaccination of hepatitis A in Korea. Journal of Korean Medical Association 2008; 51: 110–118.
32.Kyrlagkitsis, I, et al. Acute hepatitis A virus infection: a review of prognostic factors from 25 years experience in a tertiary referral center. Hepatogastroenterology 2002; 49: 524–528.
33.Rezende, G, et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology 2003; 38: 613–618.
34.Ajmera, V, et al. What factors determine the severity of hepatitis A-related acute liver failure? Journal of Viral Hepatitis 2011; 18: e167–e174.
35.Vento, S, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. New England Journal of Medicine 1998; 338: 286–290.